You are here

Superbugs, govt subsidies draw big pharma back to antibiotics

Until the past few years, firms had largely given up on new antibiotics
Saturday, July 2, 2016 - 05:50
BT_20160702_PFIZER_2366636.jpg
BIG PHARMA IN BIG BATTLE: In January, over 80 pharmaceutical, biotechnology and diagnostics firms, including Pfizer, pledged to fight antimicrobial resistance.

Sydney

BIG pharma is creeping back into development of new antibiotics after decades of largely ignoring the business due to the scant rewards offered by such medications.

With the planet on the brink of losing its miracle cures for bacterial diseases, research incentives from